Cryo-EM structures of African swine fever virus topoisomerase

ABSTRACT Type II topoisomerases ubiquitously exist in cellular organisms, where they play an essential role in resolving the topological problems of DNA. The viral type II topoisomerase encoded by the African swine fever virus (ASFV) is critical for viral replication and infection, thus representing an attractive target for antiviral drug development. Here we report two cryo-EM structures of ASFV topoisomerase P1192R in distinct conformations at an overall resolution of 3.16 Å and 3.13 Å, respectively. P1192R assembles as a homodimer with the C-gate formed by the coiled-coil domain adopting a closed or open conformation before reaction, providing the first visual evidence for the dynamic motions of the C-gate of type II topoisomerase. Comparative structural comparisons of eukaryotic homologs and P1192R reveal the unique structural features of P1192R, including the active site configuration, a flexible loop in the TOPRIM domain, an additionally inserted α-helix in the tower domain, and a pin-like structure in the C-terminal coiled-coil domain, which are important for enzyme activity and protein folding. These findings provide important insights into the structure and function of viral topoisomerases and may guide the efficient development of anti-ASFV drugs. Moreover, our study also offers structural evidence to support the scenario of the viral origin of eukaryotic type IIA topoisomerases. IMPORTANCE African swine fever virus (ASFV) is a highly contagious virus that causes lethal hemorrhagic diseases known as African swine fever (ASF) with a case fatality rate of 100%. There is an urgent need to develop anti-ASFV drugs. We determine the first high-resolution structures of viral topoisomerase ASFV P1192R in both the closed and open C-gate forms. P1192R shows a similar overall architecture with eukaryotic and prokaryotic type II topoisomerases, which have been successful targets of many antimicrobials and anticancer drugs, with the most similarity to yeast topo II. P1192R also exhibits differences in the details of active site configuration, which are important to enzyme activity. These two structures offer useful structural information for antiviral drug design and provide structural evidence to support that eukaryotic type IIA topoisomerase likely originated from horizontal gene transfer from the virus. African swine fever virus (ASFV) is a highly contagious virus that causes lethal hemorrhagic diseases known as African swine fever (ASF) with a case fatality rate of 100%. There is an urgent need to develop anti-ASFV drugs. We determine the first high-resolution structures of viral topoisomerase ASFV P1192R in both the closed and open C-gate forms. P1192R shows a similar overall architecture with eukaryotic and prokaryotic type II topoisomerases, which have been successful targets of many antimicrobials and anticancer drugs, with the most similarity to yeast topo II. P1192R also exhibits differences in the details of active site configuration, which are important to enzyme activity. These two structures offer useful structural information for antiviral drug design and provide structural evidence to support that eukaryotic type IIA topoisomerase likely originated from horizontal gene transfer from the virus.

[1]  L. Holm Dali server: structural unification of protein families , 2022, Nucleic Acids Res..

[2]  P. Forterre,et al.  Viral origin of eukaryotic type IIA DNA topoisomerases , 2022, bioRxiv.

[3]  K. Neuman,et al.  DNA topoisomerases: Advances in understanding of cellular roles and multi-protein complexes via structure-function analysis , 2021, BioEssays : news and reviews in molecular, cellular and developmental biology.

[4]  A. Leitão,et al.  The African Swine Fever Virus (ASFV) Topoisomerase II as a Target for Viral Prevention and Control , 2020, Vaccines.

[5]  J. Richt,et al.  African Swine Fever Virus: An Emerging DNA Arbovirus , 2020, Frontiers in Veterinary Science.

[6]  A. Mondragón,et al.  CryoEM structures of open dimers of gyrase A in complex with DNA illuminate mechanism of strand passage , 2018, bioRxiv.

[7]  M. Gilson,et al.  Structural insights into the gating of DNA passage by the topoisomerase II DNA-gate , 2018, Nature Communications.

[8]  H. Hiasa,et al.  Topoisomerases as anticancer targets. , 2018, The Biochemical journal.

[9]  Randy J Read,et al.  Real-space refinement in PHENIX for cryo-EM and crystallography , 2018, bioRxiv.

[10]  A. Erives Phylogenetic analysis of the core histone doublet and DNA topo II genes of Marseilleviridae: evidence of proto-eukaryotic provenance , 2017, Epigenetics & Chromatin.

[11]  A. Erives,et al.  Phylogenetic analysis of the core histone doublet and DNA topo II genes of Marseilleviridae: evidence of proto-eukaryotic provenance , 2017, Epigenetics & Chromatin.

[12]  Marius A. Micluţa,et al.  Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint , 2017, Nucleic acids research.

[13]  I. Galindo,et al.  African Swine Fever Virus: A Review , 2017, Viruses.

[14]  David J. Fleet,et al.  cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination , 2017, Nature Methods.

[15]  J. Baxter,et al.  The Causes and Consequences of Topological Stress during DNA Replication , 2016, Genes.

[16]  A. Leitão,et al.  In vitro inhibition of African swine fever virus-topoisomerase II disrupts viral replication. , 2016, Antiviral research.

[17]  A. Leitão,et al.  Functional characterization and inhibition of the type II DNA topoisomerase coded by African swine fever virus. , 2016, Virology.

[18]  A. Leitão,et al.  In vitro antiviral activity of fluoroquinolones against African swine fever virus. , 2013, Veterinary microbiology.

[19]  C. Netherton,et al.  African swine fever virus replication and genomics. , 2013, Virus research.

[20]  M. K. Kathiravan,et al.  Topoisomerase as target for antibacterial and anticancer drug discovery , 2013, Journal of enzyme inhibition and medicinal chemistry.

[21]  B. Schmidt,et al.  The structure of DNA-bound human topoisomerase II alpha: conformational mechanisms for coordinating inter-subunit interactions with DNA cleavage. , 2012, Journal of molecular biology.

[22]  B. Schmidt,et al.  Structure of a topoisomerase II-DNA-nucleotide complex reveals a new control mechanism for ATPase activity , 2012, Nature Structural &Molecular Biology.

[23]  B. Schmidt,et al.  All tangled up: how cells direct, manage and exploit topoisomerase function , 2011, Nature Reviews Molecular Cell Biology.

[24]  Lynn Farh,et al.  Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide , 2011, Science.

[25]  Kristin K. Brown,et al.  Type IIA topoisomerase inhibition by a new class of antibacterial agents , 2010, Nature.

[26]  I. Laponogov,et al.  Structural Basis of Gate-DNA Breakage and Resealing by Type II Topoisomerases , 2010, PloS one.

[27]  I. Laponogov,et al.  Structural insight into the quinolone–DNA cleavage complex of type IIA topoisomerases , 2009, Nature Structural &Molecular Biology.

[28]  J. Nitiss DNA topoisomerase II and its growing repertoire of biological functions , 2009, Nature Reviews Cancer.

[29]  P. Forterre,et al.  Phylogenomics of DNA topoisomerases: their origin and putative roles in the emergence of modern organisms , 2009, Nucleic acids research.

[30]  J. Berger,et al.  DNA topoisomerases: harnessing and constraining energy to govern chromosome topology , 2008, Quarterly Reviews of Biophysics.

[31]  J. Berger,et al.  Structural basis for gate-DNA recognition and bending by type IIA topoisomerases , 2007, Nature.

[32]  P. Forterre,et al.  Origin and evolution of DNA topoisomerases. , 2007, Biochimie.

[33]  J. V. Van Etten,et al.  Chlorella virus Marburg topoisomerase II: high DNA cleavage activity as a characteristic of Chlorella virus type II enzymes. , 2005, Biochemistry.

[34]  J. Berger,et al.  Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases. , 2004, Annual review of biophysics and biomolecular structure.

[35]  Patrick Forterre,et al.  Phylogenomics of type II DNA topoisomerases , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[36]  Deborah Fass,et al.  Quaternary changes in topoisomerase II may direct orthogonal movement of two DNA strands , 1999, Nature Structural Biology.

[37]  T. Harris,et al.  Vaccinia DNA topoisomerase I: evidence supporting a free rotation mechanism for DNA supercoil relaxation. , 1997, Biochemistry.

[38]  J. Wang,et al.  DNA transport by a type II topoisomerase: direct evidence for a two-gate mechanism. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Berger,et al.  Structure and mechanism of DNA topoisomerase II , 1996, Nature.

[40]  J. Roca,et al.  DNA transport by a type II DNA topoisomerase: Evidence in favor of a two-gate mechanism , 1994, Cell.

[41]  B. Alberts,et al.  T4 DNA topoisomerase: a new ATP-dependent enzyme essential for initiation of T4 bacteriophage DNA replication , 1979, Nature.

[42]  OUP accepted manuscript , 2022, Nucleic Acids Research.

[43]  N. Osheroff,et al.  DNA Recognition/Processing | DNA Topoisomerases: Type II , 2021, Encyclopedia of Biological Chemistry III.

[44]  Christopher J. Williams,et al.  MolProbity: More and better reference data for improved all‐atom structure validation , 2018, Protein science : a publication of the Protein Society.

[45]  H. Hiasa DNA Topoisomerases as Targets for Antibacterial Agents. , 2018, Methods in molecular biology.

[46]  A. Leitão,et al.  African swine fever virus ORF P1192R codes for a functional type II DNA topoisomerase. , 2015, Virology.

[47]  B. Schmidt,et al.  A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases , 2010, Nature.

[48]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[49]  D. J. Clarke,et al.  DNA Topoisomerases , 2009, Methods in Molecular Biology™.